Delivery Order SPE2DB24D2213-SPE2DB25FGVTH

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, with a ceiling value of $3,361.12, is for the delivery of Ondansetron ODT 4 mg tablets. It is a Firm Fixed Price Delivery Order contract, with an ultimate completion date of October 27, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,695.23, is for the delivery of Ondansetron ODT 4 mg tablets. This is a firm-fixed-price delivery order contract with a completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $25,595.07, is for the delivery of Ondansetron ODT 4 mg tablets in quantities of 30 per package. This is a Firm Fixed Price delivery order contract with an ultimate completion date of December 6, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price valued at $11,130.58 and a completion date of December 18, 2023. It covers the supply of Ondansetron ODT 4 mg tablets. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,440.98 Firm Fixed Price Delivery Order contract has a completion date of January 17, 2025. It is not a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of pharmaceutical products...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,357.89 and is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of January 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $1,280.46, is for the delivery of ondansetron ODT 4 mg tablets. It is a firm fixed-price delivery order contract with a completion date of February 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,091.76, is for the delivery of Ondansetron ODT 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,786.74, is for the delivery of ondansetron ODT 4 mg tablets. It is a firm fixed-price delivery order contract with a completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 4 mg tablets, with a ceiling value of $7,275.29 and a period of performance through January 30, 2025. This award is not associated with a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
  • SPE2DB24D2213
    Indefinite Delivery Contract
  • SPE2DB24D2213-SPE2DB25FGVTH
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,504.63 and is a delivery order for Ondansetron ODT 4 mg tablets. It is a firm fixed-price contract with a period of performance ending on January 27, 2025.

The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:02 AM